Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Goi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Leukemia|June 9, 1999
p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocationM Nakamura, K Sugita, T Inukai, et al.
Oncogene|June 6, 2012
BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemiaI Kuroda, T Inukai, X Zhang, et al.
Bone Marrow Transplantation|September 23, 2008
Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCTT Inukai, K Goi, T Tezuka, et al.
Leukemia|June 22, 1999
The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cellsK Sugita, T Mori, S Yokota, et al.
Leukemia|February 12, 2010
Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factorK Akahane, T Inukai, T Inaba, et al.
Leukemia|October 27, 2006
Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunityT Inukai, X Zhang, M Goto, et al.
Leukemia|June 30, 2012
Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsX Zhang, T Inukai, K Hirose, et al.
Cancer Research|May 15, 1997
DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutationK Goi, M Takagi, S Iwata, et al.
Leukemia|December 22, 2006
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19T Inukai, K Hirose, T Inaba, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Leukemia|June 9, 1999
p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocationM Nakamura, K Sugita, T Inukai, et al.
Oncogene|June 6, 2012
BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemiaI Kuroda, T Inukai, X Zhang, et al.
Bone Marrow Transplantation|September 23, 2008
Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCTT Inukai, K Goi, T Tezuka, et al.
Leukemia|June 22, 1999
The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cellsK Sugita, T Mori, S Yokota, et al.
Leukemia|February 12, 2010
Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factorK Akahane, T Inukai, T Inaba, et al.
Leukemia|October 27, 2006
Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunityT Inukai, X Zhang, M Goto, et al.
Leukemia|June 30, 2012
Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsX Zhang, T Inukai, K Hirose, et al.
Cancer Research|May 15, 1997
DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutationK Goi, M Takagi, S Iwata, et al.
Leukemia|December 22, 2006
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19T Inukai, K Hirose, T Inaba, et al.
Pageof 4